Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AKTIP pseudogene 3 (AKTIPP3) is a pseudogene, which means it is a segment of DNA that closely resembles the sequence of the functional *AKTIP* gene but has accumulated disabling mutations that prevent it from coding for a functional protein[1][5][3]. Pseudogenes are typically regarded as nonfunctional remnants of evolutionarily duplicated or retrotransposed genes[1][5]. While some pseudogenes across the genome may exert regulatory influence (e.g., through RNA transcripts), the majority—including AKTIP pseudogene 3—are not known to have any current biological or clinical significance[1][3][5][6]. The true, protein-coding AKTIP gene has recognized roles in cell signaling and cancer, but AKTIPP3 is merely a vestigial sequence and does not function as a receptor, enzyme, transporter, or other drug target[2][4].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AKTIP pseudogene 3 (AKTIPP3).